MSLs, R&D, ClinOps, and Pharmacovigilance teams now map every KOL and DOL, detect emerging trends in real time, and accelerate clinical timelines — all on one predictive intelligence layer wired to 186,503 contacts and the social corpus as of Mar 2026.
Scientific affairs stops curating yesterday’s publication lists and starts acting on live behavior — posts, congresses, trial participation, and peer graphs, all fused into a single, governed intelligence layer.
MSL, R&D, ClinOps, and PV each operate on the same KOL graph, the same signal stream, and the same ontology — with surfaces tuned to their work.
Every KOL scored on a six-dimensional influence model — publications, congresses, peer graph, patient reach, payer affinity, and live social velocity. Filter poachable KOLs in one motion.
Catch emerging trends the moment they leave the clinic floor — trap-tox, jawline biostimulators, scar-focused PRF — with provenance back to every post and every injector.
Run geographic + specialty + velocity filters on the full injector graph. Build site clusters that pass ethics, logistics, and recruitment reality checks — before the first PI call.
Triage-ready alerts from the scored social corpus — off-label language, adverse-event mentions, misuse patterns — with provenance, timestamps, and an MLR-ready audit trail.
The KOL network, the poaching matrix, and the innovation feed are the same three surfaces Medical Affairs teams open every morning inside Axiogen.
Toxin injection into trapezius for neckline aesthetic. 41 posts across T1 injectors in 30 days. +412% week-over-week.
Off-label combination of PLLA biostimulators with HA filler along mandibular angle. 27 injectors, rapid patient-demand lift.
Nurse-led accounts driving 3× engagement vs. board-certified on PRF scar revision content. Education content velocity surging.
Low-dose injectable skin-booster protocols increasingly mentioned alongside maintenance toxin cadence.
Filter by region, treatment area, minimum injector count, and live social velocity. Axiogen builds cluster-ready site maps with provenance on every qualification signal.
A 15-minute briefing, a live KOL mapping query on your therapeutic area, and a concrete rollout plan across MSL, R&D, ClinOps, and Pharmacovigilance.